Search results
Forget Nvidia, Buy This Magnificent Healthcare Stock Instead
Motley Fool via Yahoo Finance· 1 day agoThe rheumatoid arthritis drug's sales declined by nearly 36% during the period, falling to less than...
Lilly (LLY) Hits Record High on Crohn's Disease Study Data
Zacks via Yahoo Finance· 5 days agoThe targeted CD markets are highly competitive. If approved, Lilly will face stiff competition from...
1 Wall Street Analyst Thinks AbbVie Stock Is Going to $200. Is It a Buy at Around $165?
Motley Fool via Yahoo Finance· 7 days agoU.S. sales of Humira plummeted by 39.9% year over year in the first quarter to $1.8 billion....
Why AbbVie (ABBV) is a Top Value Stock for the Long-Term
Zacks via Yahoo Finance· 4 days agoWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the...
NBC's 'SNL' 50th Anniversary Season Signs 4 Presenting Sponsors
MediaPost· 7 days agoNBC has inked four season-long "presenting sponsors" for the 50th anniversary season of longtime weekend late-night show "Saturday Night Live."
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
Motley Fool via Yahoo Finance· 2 days agoThe company began facing biosimilar competition for its top-selling drug, Humira, last year....
State board targets six prescription drugs to review for affordability for Marylanders
Maryland Matters via Yahoo News· 7 days agoThe board will seek public comments, additional information and data over the next 60 days to...
Maryland Drug Board Advances Ozempic, Other Cost Reviews (1)
Bloomberg Law· 7 days agoBlockbuster diabetes drugs Ozempic and Trulicity will be included in the Maryland prescription drug board’s first cost review, a monthslong process that will help the panel determine whether ...
AbbVie (NYSE:ABBV) vs. Cosmo Pharmaceuticals (OTC:CMOPF) Head to Head Review
ETF DAILY NEWS· 3 days agoAbbVie (NYSE:ABBV – Get Free Report) and Cosmo Pharmaceuticals (OTC:CMOPF – Get Free Report) are both medical companies, but which is the better investment? We will compare the two businesses ...
This Is What Whales Are Betting On AbbVie - AbbVie (NYSE:ABBV)
Benzinga· 5 days agoThe company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including ...